Stock Analysis on Net
Stock Analysis on Net

Express Scripts Holding Co. (NASDAQ:ESRX)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2018.

Return on Equity (ROE)
since 2005

Microsoft Excel

Paying user area

Try for free

Express Scripts Holding Co. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Express Scripts Holding Co., ROE, long-term trends, calculation

Microsoft Excel
ROE = 100 × Net income attributable to Express Scripts1 ÷ Total Express Scripts stockholders’ equity1
Dec 31, 2017 = 100 × ÷
Dec 31, 2016 = 100 × ÷
Dec 31, 2015 = 100 × ÷
Dec 31, 2014 = 100 × ÷
Dec 31, 2013 = 100 × ÷
Dec 31, 2012 = 100 × ÷
Dec 31, 2011 = 100 × ÷
Dec 31, 2010 = 100 × ÷
Dec 31, 2009 = 100 × ÷
Dec 31, 2008 = 100 × ÷
Dec 31, 2007 = 100 × ÷
Dec 31, 2006 = 100 × ÷
Dec 31, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

The data indicates a generally positive trajectory in net income attributable to Express Scripts over the analyzed period. From 2005 to 2017, net income increased significantly, rising from $400 million to approximately $4.52 billion. This represents more than a tenfold increase in net income, with particularly notable growth after 2013, where income rose from about $1.84 billion to upwards of $4.5 billion by the end of 2017.

Total stockholders’ equity exhibits more variability over the same period. Initially, equity declined from $1.47 billion in 2005 to $696 million in 2007, suggesting possible losses or distributions exceeding earnings in those years. However, from 2008 onwards, equity showed a marked increase, peaking dramatically at $23.39 billion in 2012. After this peak, stockholders' equity declined steadily until 2016, when it was approximately $16.24 billion, followed by a moderate increase to $18.12 billion in 2017. These fluctuations may reflect changes in capital structure, share transactions, or revaluation adjustments.

The Return on Equity (ROE) metric experienced substantial fluctuations during the period. ROE was highest in the early years, reaching above 80% in 2007 and maintaining elevated levels through 2008. Following these peaks, it declined significantly to a low of approximately 5.61% in 2012, coinciding with the peak in stockholders' equity. Subsequently, ROE gradually improved, increasing each year to approximately 24.93% in 2017. This pattern suggests that periods of very high earnings relative to equity were followed by equity expansions that moderated returns, but over time, profitability relative to equity strengthened again.

Overall, net income growth outpaced equity growth in the later years, which likely contributed to the recovery and enhancement of ROE after its mid-period trough. The trends indicate strong earnings performance and resilience, particularly in the final years of the dataset, despite significant equity base changes.

Comparison to Competitors

Express Scripts Holding Co., ROE, long-term trends, comparison to competitors

Microsoft Excel
Express Scripts Holding Co. Abbott Laboratories CVS Health Corp. Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Health Care Equipment & Services)

Express Scripts Holding Co., ROE, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel
Express Scripts Holding Co. Health Care Equipment & Services
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Express Scripts Holding Co., ROE, long-term trends, comparison to industry (health care)

Microsoft Excel
Express Scripts Holding Co. Health Care
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).